Pitavastatin Calcium

CAS 147526-32-7 12 current records 2 historicalSmall Molecule

Who holds supplier records for Pitavastatin Calcium? 12 organisations hold a current record for Pitavastatin Calcium: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (7), Japan (1), Taiwan (1) and South Korea (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Pitavastatin Calcium: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/pitavastatin-calcium

Reading the evidence

  • 12 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    7 of the 10 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 8 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (12)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Pitavastatin Calcium. Country is the organisation's recorded country, not necessarily the manufacturing site.

India7Japan1Taiwan1South Korea1Country not recorded for 2
Need Pitavastatin Calcium sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (2)

Organisations whose Type II DMFs for Pitavastatin Calcium are no longer active. These show a past filing, not current supply.

Show all 2 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Pitavastatin Calcium is a cholesterol-lowering medication (statin) used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body.

Chemical identity

IUPAC name
calcium bis((E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate)
Canonical SMILES
C1C(C1)C2=NC3=CC=CC=C3C(=C2/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C4=CC=C(C=C4)F.C1C(C1)C2=NC3=CC=CC=C3C(=C2/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C4=CC=C(C=C4)F.[Ca+2]
InChIKey
RHGYHLPFVJEAOC-FFNUKLMVSA-L
Synonyms
Livalo API, itavastatin calcium, livalo, nk-104, pitavastatin calcium salt, pitavastatin hemicalcium

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
HMG-CoA Reductase Inhibitor
Mechanism of action
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Therapeutic areas

CardiovascularDyslipidemia

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Pitavastatin Calcium?

12 organisations hold an active US FDA Type II Drug Master File or a CEP for Pitavastatin Calcium: APITORIA PHARMA PRIVATE LTD (India), NISSAN CHEMICAL CORP (Japan), Formosa Laboratories, Inc. (Taiwan), FUXIN LONG RUI PHARMACEUTICAL CO LTD, Hetero Drugs Limited (India), Kolon Life Science, Inc. (코오롱생명과학) (South Korea), Lupin Limited (India) and MATRIX PHARMACORP PRIVATE LTD (India), and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Pitavastatin Calcium Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 27106, 41330), NISSAN CHEMICAL CORP (DMF 14660, 27761), Formosa Laboratories, Inc. (DMF 42530), FUXIN LONG RUI PHARMACEUTICAL CO LTD (DMF 33489), Hetero Drugs Limited (DMF 27255), Kolon Life Science, Inc. (코오롱생명과학) (DMF 32169), Lupin Limited (DMF 27242) and MATRIX PHARMACORP PRIVATE LTD (DMF 27144) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Pitavastatin Calcium records mean?

2 organisations have only inactive Type II DMFs for Pitavastatin Calcium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Pitavastatin Calcium supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Pitavastatin Calcium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.